Acumen Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
15.83
|
|
Average Rating
|
4.60
|
|
# Strong Buys
|
3
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.33
|
0.00
|
0.33
|
100.00%
|
|
2022-12-31
|
-0.28
|
0.00
|
0.28
|
100.00%
|
|
2022-09-30
|
-0.23
|
-0.26
|
-0.03
|
-13.04%
|
|
2022-06-30
|
-0.24
|
-0.25
|
-0.01
|
-4.17%
|
|
2022-03-31
|
-0.17
|
-0.23
|
-0.06
|
-35.29%
|
|
2021-12-31
|
-0.14
|
-0.42
|
-0.28
|
-200.00%
|
|
2021-09-30
|
-0.17
|
-0.10
|
0.07
|
41.18%
|
|
2021-06-30
|
-4.56
|
-7.91
|
-3.35
|
-73.46%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.74
|
|
2021-12-31
|
-9.37
|
|
2020-12-31
|
-64.40
|
|
2019-12-31
|
-4.88
|